Results 171 to 180 of about 172,270 (305)
Prestorage Leukoreduction of Canine Blood Products: A Critically Appraised Topic. [PDF]
Proverbio D, Perego R, Spada E.
europepmc +1 more source
[Reactions in erythrocyte transfusion].
A I, KIZILOVA, E S, SAL'KOVSKAIA
openaire +1 more source
Abstract Objective This study aimed to analyse the distribution and demand patterns of antigen‐negative red blood cells (RBCs) in Shandong Province, China (2022–2024), with a focus on ABO blood groups and clinically significant antigens. The research was designed to provide rigorous data for advancing precision transfusion protocols and to establish a ...
Aiping Zhao +7 more
wiley +1 more source
Long-term safety and effectiveness of romiplostim in patients with refractory aplastic anemia: a nationwide, all-case, post-marketing surveillance study in Japan. [PDF]
Itagaki M +5 more
europepmc +1 more source
Abstract Background Thrombocytopenia arises from heterogeneous inherited and acquired disorders, and identifying the underlying platelet clearance mechanisms remains challenging. Platelet desialylation, characterised by loss of sialic acid and consequent exposure of terminal β‐galactose residues recognised by the Ashwell–Morell receptor, represents an ...
Karen Nogueira Chinoca Ziza +14 more
wiley +1 more source
Simple image analysis for reliability control of column agglutination test in pretransfusion testing
Abstract Objectives A novel meniscus‐based analysis provides a rapid method to identify analytical errors related to unrecognised pipetting errors. Background The indirect antihuman globulin test (IAT) is part of pretransfusion testing, enabling detection of erythrocyte alloantibodies.
Martin Töffner Pedersen +5 more
wiley +1 more source
Contemporary Management of Thalassemia: A Perspective on Current Standards and the Emergence of FDA-Approved Oral Therapy. [PDF]
Zainab F, Hasan AH, Abid MH, Abid MA.
europepmc +1 more source
Fucosylation limits ADCC in clinically used anti‐RhD monoclonal antibodies
Abstract Background Haemolytic disease of the fetus and newborn (HDFN) is caused by maternal alloantibodies, often targeting the D antigen on fetal red blood cells. Maternal immunization is preventable with timely administration of anti‐D polyclonal antibodies (pAbs).
Gabriela Koike +33 more
wiley +1 more source
Complement-Dominant Relapse of Mixed Autoimmune Hemolytic Anemia After Rituximab Response. [PDF]
Tomigaki N +12 more
europepmc +1 more source
Abstract Study Question To describe the blood product utilization during neonatal and pediatric extracorporeal membrane oxygenation (ECMO) and to determine whether its usage correlates with clinical outcomes of bleeding, thrombosis or mortality. Design Prospective observational study of neonatal and pediatric ECMO patients from September 2016, until ...
Rebecca Barton +15 more
wiley +1 more source

